Return on average equity - 5 year average | 21.91 |
Net Income/employee - trailing 12 month | - |
Revenue/employee - most recent fiscal year | - |
Return on investment - most recent fiscal year | 38.56 |
Return on average assets - most recent fiscal year | 24.26 |
Receivables turnover - most recent fiscal year | 2.73 |
Return on investment - trailing 12 month | 26.37 |
Return on average assets - trailing 12 month | 18.62 |
Inventory turnover - most recent fiscal year | 16.26 |
Inventory turnover - trailing 12 month | 4.73 |
Revenue/employee - trailing 12 month | - |
Return on average assets - 5 year average | 10.29 |
Net Income/employee - most recent fiscal year | - |
Return on average equity - trailing 12 month | 29.31 |
Receivables turnover - trailing 12 month | 2.39 |
Asset turnover - most recent fiscal year | 0.98 |
Asset turnover - trailing 12 month | 0.50 |
Return on average equity - most recent fiscal year | 44.70 |
Return on investment - 5 year average | 15.49 |
Shukra Pharmaceuticals Dividend Shukra Pharmaceuticals Bonus Shukra Pharmaceuticals News Shukra Pharmaceuticals AGM Shukra Pharmaceuticals Rights Shukra Pharmaceuticals Splits Shukra Pharmaceuticals Board Meetings Shukra Pharmaceuticals Shareholdings Shukra Pharmaceuticals Profit Loss Shukra Pharmaceuticals Balance Sheet Shukra Pharmaceuticals Cashflow Shukra Pharmaceuticals Q1 Results Shukra Pharmaceuticals Q2 Results Shukra Pharmaceuticals Q3 Results Shukra Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks